The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Lobar or Sublobar Resection for Peripheral Stage IA Non–Small-Cell Lung Cancer
Open accessAbstract
BACKGROUND: The increased detection of small-sized peripheral non-small-cell lung cancer (NSCLC) has renewed interest in sublobar resection in lieu of lobectomy. METHODS: We conducted a multicenter, noninferiority, phase 3 trial in which patients with NSCLC clinically staged as T1aN0 (tumor size, ≤2 cm) were randomly assigned to undergo sublobar resection or lobar resection after intraoperative confirmation of node-negative disease. The primary end point was disease-free survival, defined as the time between randomization and disease recurrence or death from any cause. Secondary end points were overall survival, locoregional and systemic recurrence, and pulmonary functions. RESULTS: From June 2007 through March 2017, a total of 697 patients were assigned to undergo sublobar resection (340 patients) or lobar resection (357 patients). After a median follow-up of 7 years, sublobar resection was noninferior to lobar resection for disease-free survival (hazard ratio for disease recurrence or death, 1.01; 90% confidence interval [CI], 0.83 to 1.24). In addition, overall survival after sublobar resection was similar to that after lobar resection (hazard ratio for death, 0.95; 95% CI, 0.72 to 1.26). The 5-year disease-free survival was 63.6% (95% CI, 57.9 to 68.8) after sublobar resection and 64.1% (95% CI, 58.5 to 69.0) after lobar resection. The 5-year overall survival was 80.3% (95% CI, 75.5 to 84.3) after sublobar resection and 78.9% (95% CI, 74.1 to 82.9) after lobar resection. No substantial difference was seen between the two groups in the incidence of locoregional or distant recurrence. At 6 months postoperatively, a between-group difference of 2 percentage points was measured in the median percentage of predicted forced expiratory volume in 1 second, favoring the sublobar-resection group. CONCLUSIONS: In patients with peripheral NSCLC with a tumor size of 2 cm or less and pathologically confirmed node-negative disease in the hilar and mediastinal lymph nodes, sublobar resection was not inferior to lobectomy with respect to disease-free survival. Overall survival was similar with the two procedures. (Funded by the National Cancer Institute and others; CALGB 140503 ClinicalTrials.gov number, NCT00499330.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Proportional Hazards Model for the Subdistribution of a Competing Risk
Fine, J. P., & Gray, R. J. (1999) · Journal of the American Statistical Association · doi:10.1080/01621459.1999.10474144 · Cited by 14,290
A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk
Gray, R. J. (1988) · The Annals of Statistics · doi:10.1214/aos/1176350951 · Cited by 4,960
A Multiple Testing Procedure for Clinical Trials
O'Brien, P. C., & Fleming, T. R. (1979) · Biometrics · doi:10.2307/2530245 · Cited by 3,311
Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer
Ginsberg, R. J., & Rubinstein, L. V. (1995) · The Annals of Thoracic Surgery · doi:10.1016/0003-4975(95)00537-u · Cited by 3,006
Discrete sequential boundaries for clinical trials
GORDON LAN, K. K., & DEMETS, D. L. (1983) · Biometrika · doi:10.1093/biomet/70.3.659 · Cited by 2,310
Saji, H., Okada, M., Tsuboi, M., Nakajima, R., Suzuki, K., Aokage, K., Aoki, T., Okami, J., Yoshino, I., Ito, H., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(21)02333-3 · Cited by 1,729
Comparative analysis of two rates
Miettinen, O., & Nurminen, M. (1985) · Statistics in Medicine · doi:10.1002/sim.4780040211 · Cited by 1,110
Boffa, D. J., Allen, M. S., Grab, J. D., Gaissert, H. A., Harpole, D. H., & Wright, C. D. (2008) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2007.07.060 · Cited by 497
Altorki, N. K., Wang, X., Wigle, D., Gu, L., Darling, G., Ashrafi, A. S., Landrenau, R., Miller, D., Liberman, M., Jones, D. R., et al. (2018) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(18)30411-9 · Cited by 380
Self-citationSublobar resection is equivalent to lobectomy for clinical stage 1A lung cancer in solid nodules
Altorki, N. K., Yip, R., Hanaoka, T., Bauer, T., Aye, R., Kohman, L., Sheppard, B., Thurer, R., Andaz, S., Smith, M., et al. (2014) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2013.09.065 · Cited by 330
Self-citation
Cited by
Cusumano, G., D'arrigo, S., Terminella, A., & Lococo, F. (2024) · doi:10.20944/preprints202405.0759.v1 · Cited by 14
Rapid On-Site AI-Assisted Grading for Lung Surgery Based on Optical Coherence Tomography
Liu, H.-C., Lin, M.-H., Chang, W.-C., Zeng, R.-C., Wang, Y.-M., & Sun, C.-W. (2023) · Cancers · doi:10.3390/cancers15225388 · Cited by 9
Metadata
- Authors
- Altorki, N., Wang, X., Kozono, D., Watt, C., Landrenau, R., Wigle, D., Port, J., Jones, D. R., Conti, M., Ashrafi, A. S., Liberman, M., Yasufuku, K., Yang, S., Mitchell, J. D., Pass, H., Keenan, R., Bauer, T., Miller, D., Kohman, L. J., Stinchcombe, T. E., & Vokes, E.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2023-02-09
- Volume
- 388
- Issue
- 6
- Pages
- 489-498
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W4319456746
- Cited by
- 1,106
- References
- 14
- FWCI
- 176.17
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Lobar or Sublobar Resection for Peripheral Stage IA Non–Small-Cell Lung Cancer. https://app.cochat.ai/papers/10.1056/nejmoa2212083
- The paper
- Altorki, N., Wang, X., Kozono, D., Watt, C., Landrenau, R., Wigle, D., Port, J., Jones, D. R., Conti, M., Ashrafi, A. S., Liberman, M., Yasufuku, K., Yang, S., Mitchell, J. D., Pass, H., Keenan, R., Bauer, T., Miller, D., Kohman, L. J., . . . Vokes, E. (2023). Lobar or Sublobar Resection for Peripheral Stage IA Non–Small-Cell Lung Cancer. New England Journal of Medicine. https://doi.org/10.1056/nejmoa2212083
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.